At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MSB Mesabi
Market Closed 07-10 16:00:00 EDT
25.10
-0.23
-0.91%
盘后25.10
+0.000.00%
16:10 EDT
High25.90Low24.74Vol38.99K
Open25.31D1 Closing25.33Amplitude4.58%
Mkt Cap329.31MTradable Cap329.06MTotal Shares13.12M
T/O977.98KT/O Rate0.30%Tradable Shares13.11M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?
Simply Wall St.  ·  07-12 08:28
Mesoblast (ASX:MSB) Is Up 8.7% After Strong Ryoncil Debut And FDA BLA Milestone - Has The Bull Case Changed?
Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026
Dow Jones  ·  07-10 08:30
Press Release: Ryoncil(r) Delivers Net Revenue of Us$36m for the Fourth Quarter Ended 30 June 2026
Why Mesoblast (ASX:MSB) Is Up 9.3% After FDA Accepts Modular BLA Review For Rexlemestrocel-L
Simply Wall St.  ·  07-04
Why Mesoblast (ASX:MSB) Is Up 9.3% After FDA Accepts Modular BLA Review For Rexlemestrocel-L
Treasure Global Recieves Canadian MSB Registration for OXI Wallet Expansion
MT Newswires Live  ·  07-02
Treasure Global Recieves Canadian MSB Registration for OXI Wallet Expansion
Is Mesoblast (ASX:MSB) Undervalued Following FDA Progress For Rexlemestrocel L?
Simply Wall St.  ·  07-02
Is Mesoblast (ASX:MSB) Undervalued Following FDA Progress For Rexlemestrocel L?
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
GlobeNewswire  ·  07-01
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADs
OwlTing Group (NASDAQ: OWLS) and Saber Money Open Settlement into India's US$860 Billion Export Economy
GlobeNewswire  ·  06-29
OwlTing Group (NASDAQ: OWLS) and Saber Money Open Settlement into India's US$860 Billion Export Economy
Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility
Dow Jones  ·  06-25
Press Release: Mesoblast Draws US$50 Million from Five-year Non-dilutive Facility
Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed?
Simply Wall St.  ·  06-21
Mesoblast (ASX:MSB) Is Up 9.2% After Ryoncil’s Near-US$100m Debut And Revascor FDA Progress – Has The Bull Case Changed?
Mesabi Trust Q1 FY27 net income drops 70.05% to $1.09 million
Reuters  ·  06-13
Mesabi Trust Q1 FY27 net income drops 70.05% to $1.09 million
Press Release: Mesabi Metallics Monetizes Portion of Royalty Interest for $265 Million
Dow Jones  ·  06-02
Press Release: Mesabi Metallics Monetizes Portion of Royalty Interest for $265 Million
The Metals Royalty Company Inc. Closes Mesabi Royalty Acquisition, Exercises Option to Acquire an Additional 1% Royalty Interest and Appoints Michael Hess as Non-Executive Co-Chairman
TIPRANKS  ·  06-02
The Metals Royalty Company Inc. Closes Mesabi Royalty Acquisition, Exercises Option to Acquire an Additional 1% Royalty Interest and Appoints Michael Hess as Non-Executive Co-Chairman
The Metals Royalty Company Acquires Mesabi Royalty; Names Michael Hess as Non-Executive Co-Chairman
MT Newswires Live  ·  06-02
The Metals Royalty Company Acquires Mesabi Royalty; Names Michael Hess as Non-Executive Co-Chairman
Assessing Mesoblast (ASX:MSB) Valuation After Phase 3 Recruitment Milestone For Rexlemestrocel L
Simply Wall St.  ·  05-07
Assessing Mesoblast (ASX:MSB) Valuation After Phase 3 Recruitment Milestone For Rexlemestrocel L
Mesabi Trust Reports Higher Shipments But No Bonus Royalties
TIPRANKS  ·  05-05
Mesabi Trust Reports Higher Shipments But No Bonus Royalties
Is Completing Phase 3 Enrollment For Rexlemestrocel-L Reshaping The Investment Case For Mesoblast (ASX:MSB)?
Simply Wall St.  ·  05-02
Is Completing Phase 3 Enrollment For Rexlemestrocel-L Reshaping The Investment Case For Mesoblast (ASX:MSB)?
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
GlobeNewswire  ·  04-29
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
Mesabi Trust (MSB) Q3 Net Margin Strengthens Bearish Dividend Coverage Narratives
Simply Wall St.  ·  04-24
Mesabi Trust (MSB) Q3 Net Margin Strengthens Bearish Dividend Coverage Narratives
Mesabi Trust publishes fiscal 2026 annual report
Reuters  ·  04-23
Mesabi Trust publishes fiscal 2026 annual report
Mesoblast (ASX:MSB) Is Up 6.1% After FDA Clears Registrational DMD Trial for Ryoncil
Simply Wall St.  ·  04-19
Mesoblast (ASX:MSB) Is Up 6.1% After FDA Clears Registrational DMD Trial for Ryoncil

Introduction

Company Name.
Mesabi
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
Mesabi Trust, a royalty trust, engages in iron ore mining business in the United States. Mesabi Trust was founded in 1961 and is based in New York, New York.
Issue price:
--